comparemela.com

Latest Breaking News On - Nyse enz - Page 4 : comparemela.com

Enzo Biochem Reports First Quarter Fiscal Year 2023

- Enzo Life Sciences reports revenue of $7.1 million and 9% growth in Q1 FY 2023, excluding FX - Engagement with investment bank to provide advisory.

Enzo loopAsia pacificHamid erfanianEnzo biochemEnzo clinical lab servicesEnzo biochem incYork state department of healthEnzo life sciencesLife sciencesFiscal yearClinical lab servicesNew york state departmentNyse enzEnzo biochem

Enzo Biochem, Inc to Report First Quarter Fiscal 2023

Conference Call and Webcast Scheduled for December 13th, 8:30 AM ET New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) Enzo Biochem, Inc..

New yorkUnited statesPatricia eckertLynn granitoChris calabreseCompany formEnzo biochemLifesci advisorsBerry company public relationsSecurities exchangeEnzo biochem incConference callWebcast scheduledInvestor relationsSecurities actSecurities exchange act

Enzo Biochem, Inc Announces Date of Annual Shareholders

NEW YORK, NY, Nov. 08, 2022 (GLOBE NEWSWIRE) Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company,.

Lynn granitoChris calabreseEnzo biochemLifesci advisorsCompany formBerry companyEnzo biochem incSecurities exchangeAnnual shareholder meetingSecurities actSecurities exchange actRisk factorsSci advisorsNyse enzEnzo biochem

Insider Buying: Enzo Biochem, Inc (NYSE:ENZ) CEO Buys 4,600 Shares of Stock

Enzo Biochem, Inc. (NYSE:ENZ – Get Rating) CEO Hamid Erfanian acquired 4,600 shares of the company’s stock in a transaction that occurred on Wednesday, June 15th. The shares were acquired at an average price of $2.19 per share, for a total transaction of $10,074.00. Following the purchase, the chief executive officer now owns 274,600 shares […]

Hamid erfanianEnzo biochemShufro rose coFinancial groupSecurities exchange commissionBlackrock incLife sciences productsYork mellon corpFuller thaler asset management incEnzo biochem incClinical laboratory servicesGet ratingExchange commissionThaler asset managementNew york mellon corpShufro rose

Enzo Biochem to Report Third Quarter 2022 Financial Results

Conference Call and Webcast Scheduled for June 9, 2022, 4:30 pm ET NEW YORK, NY, June 02, 2022 (GLOBE NEWSWIRE) Enzo Biochem, Inc. (NYSE:ENZ),.

Lynn granitoChris calabreseCompany formEnzo biochemLifesci advisorsBerry company public relationsSecurities exchangeEnzo biochem incConference callWebcast scheduledSecurities actSecurities exchange actRisk factorsSci advisorsNyse enzEnzo biochem

vimarsana © 2020. All Rights Reserved.